Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN | BSE: 537291

Mid-range Performer

Download real time

145.85 -1.82 (-1.23%)

44.82% Fall from 52W High

57,874 NSE+BSE Volume

NSE 28 Mar, 2025 3:53 PM (IST)

277.2

Market Cap

Below industry Median

1.2

Beta 1Year

High Volatility

Nath Bio-Genes (India) Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nath Bio-Genes (India) Ltd. from all sources in a single place.

Nath Bio-Genes (India) Ltd.

27 Mar 2025, 03:39PM

145.85

-1.23%

SAST

Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window

BSE India

Closure of Trading Window

Nath Bio-Genes (India) Ltd.

25 Jan 2025

145.85

-1.23%

Investor Presentation

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on financial results for 31st December 2024.

Nath Bio-Genes (India) Ltd.

23 Jan 2025

145.85

-1.23%

Result

Nath Bio-Genes (India) Ltd - 537291 - Outcome of Board Meeting

BSE India

Nath Bio-Genes (India) Ltd has informed BSE regarding Outcome of Board Meeting held on January 23, 2025.

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	37.35	32.27	31.78	15.7%	17.5%
Operating Profit Qtr	8.04	4.81	5.65	67.2%	42.3%
Net Profit Qtr	2.65	1.11	3.83	138.7%	-30.8%
Earning Per Share Adjusted latest Qtr	1.39	0.59	2.02	135.6%	-31.2%

* Consolidated data

Detailed Results

Nath Bio-Genes (India) Ltd.

15 Jan 2025

145.85

-1.23%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results …

BSE India

Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve unaudited financial results for the period ended 31st December 2024

Nath Bio-Genes (India) Ltd.

14 Jan 2025

145.85

-1.23%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018 for the period ended 31st December 2024.

Nath Bio-Genes (India) Ltd.

26 Dec 2024

145.85

-1.23%

SAST

Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window

BSE India

Closure of Trading Window

Nath Bio-Genes (India) Ltd.

06 Dec 2024

145.85

-1.23%

Corp. Note

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation for Loss of Share Certificate

Nath Bio-Genes (India) Ltd.

28 Nov 2024, 04:39PM

145.85

-1.23%

Corp. Note

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Compliance Certificate under Reg 39(3) of SEBI.

Nath Bio-Genes (India) Ltd.

28 Oct 2024

145.85

-1.23%

Earnings Call

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Conference call held on 24th October 2024.

Nath Bio-Genes (India) Ltd.

28 Oct 2024, 03:43PM

145.85

-1.23%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation

No results found

Is Nath Bio-Genes (India) Ltd. worth buying?

120 Votes:

Buy 83.33%

Sell 11.67%

Hold 5.0%